More on SABS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.3 Score)

Upcoming Events

- Earnings (11/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

SAB Biotherapeutics (NQ:SABS)
Delayed: 2.53 -0.06 (2.32%)
Prev. Close $2.59  
Open$2.59 
52 Wk High$ 
52 Wk Low$ 
Day High$2.63 
Day Low$2.47 
P/E N/A  
EPS$ 
Volume756,995 

Friends, Peers and Foes (?): SABSW EBS (more...)

Oct 13, 2026 08:36 AM Form 8-K SAB Biotherapeutics, For: Oct 13
Oct 1, 2026 08:30 AM SAB BIO to Present SAB-142 Data at the Inaugural Breakthrough T1D Clinical & Research Congress
Sep 18, 2026 04:15 PM Form 4 SAB Biotherapeutics, For: Sep 17 Filed by: Kropotova Alexandra
Aug 21, 2026 04:30 PM Form 424B3 SAB Biotherapeutics,
Aug 14, 2026 05:24 PM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: PERCEPTIVE ADVISORS LLC
Aug 14, 2026 04:53 PM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Caligan Partners LP
Aug 14, 2026 04:14 PM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Commodore Capital LP
Aug 14, 2026 04:13 PM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Vivo Opportunity Fund Holdings, L.P.
Aug 14, 2026 11:04 AM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: Woodline Partners LP
Aug 14, 2026 06:14 AM Form SCHEDULE 13G/A SAB Biotherapeutics, Filed by: BALYASNY ASSET MANAGEMENT L.P.
View All Articles

Entities mentioned with SABS

View All Entities